Analytical variables of reverse transcription-polymerase chain reaction- based detection of disseminated prostate cancer cells

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2741-2750

  Zippelius, Alfred ^a   Lutterbüse, Ralf ^a   Riethmüller, Gert ^a   Pantel, Klaus ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANALYTIC METHOD; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW CELLS; GENE AMPLIFICATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033912003     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sidransky, D. Nucleic acid-based methods for the detection of cancer. Science (Washington DC), 278: 1054-1058, 1997.
2. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., and Nadler, L. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma [see comments]. N. Engl. J. Med., 325: 1525-1533, 1991.
3. Gribben, J. G., Neuberg, D., Barber, M., Moore, J., Pesek, K. W., Freedman, A. S., and Nadler, L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 83: 3800-3807, 1994.
4. Solomon, E., Borrow, J., and Goddard, A. D. Chromosome aberrations and cancer. Science (Washington DC), 254: 1153-1160, 1991.
5. Bos, J. L. Ras oncogenes in human cancer: a review [published erratum appears in Cancer Res., 50: 1352, 1990]. Cancer Res., 49: 4682-4689, 1989.
6. Brawer, M. K. Prostate specific antigen: a review. Acta Oncol., 30: 161-168, 1991.
7. Clements, J. A. The human kallikrein gene family: a diversity of expression and function. Mol. Cell. Endocrinol., 99: C1-C6, 1994.
8. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
9. Corey, E., Arfman, E. W., Oswin, M. M., Melchior, S. W., Tindall, D. J., Young, C. Y., Ellis, W. J., and Vessella, R. L. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology, 50: 184-188, 1997.
10. Ellis, W. J., Vessella, R. L., Corey, E., Arfman, E. W., Oswin, M. M., Melchior, S., and Lange, P. H. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and follow up of patients with prostate cancer [see comments]. J. Urol., 159: 1134-1138, 1998.
11. Olsson, C. A., de Vries, G. M., Buttyan, R., and Katz, A. E. Reverse transcriptase-polymerase chain reaction assays for prostate cancer. Urol. Clin. North Am., 24: 367-378, 1997.
12. Smith, M., Biggar, S., and Hussain, M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res., 55: 2640-2644, 1995.
13. Henke, W., Jung, M., Luin, M., Schelte, H., Berndt, C., Rudolph, B., Schnorr, D., and Loening, S. A. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases specificity of detection of prostatic cells in blood. Int. J. Cancer, 70: 52-56, 1997.
14. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
15. Riegman, P., Klaassen, P., van der Korput, J., Romijn, J., and Trapman, J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem. Biophys. Res. Commun., 155: 181-188, 1988.
16. Zippelius, A., Kufer, P., Honold, G., Kollermann, M. W., Oberneder, R., Schlimok, G., Riethmuller, G., and Pantel, K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow [see comments]. J. Clin. Oncol., 15: 2701-2708, 1997.
17. Thein, S., and Wallace, R. The use of synthetic oligonucleotides as specific hybridization probes in the diagnosis of genetic disorders. In: K. E. Davis (ed.), Human Genetic Diseases: A Practical Approach. Herndon, VA: IRL Press, 1986.
18. Ruano, G., Brash, D., and Kidd, K. PCR: the first few cycles. Amplifications: a Forum for PCR Users, 7: 1-4, 1991.
19. Rolfs, A., Schuller, I., Finckh, U., and Weber-Rolfs, I. PCR principles and reaction components. In: PCR: Clinical Diagnostics and Research, pp. 1-21. New York: Springer-Verlag, 1992.
20. Akane, A., Matsubara, K., Nakamura, H., Takahashi, S., and Kimura, K. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from blood stains, a major inhibitor of polymerase chain reaction (PCR) amplification. J. Forensic Sci., 39: 362-372, 1994.
21. Beutler, E., Gelbart, T., and Kuhl, W. Interference of heparin with the polymerase chain reaction. Biotechniques, 9: 166, 1990.
22. Pantel, K. Detection of minimal disease in patients with solid tumors. J. Hematother., 5: 359-367, 1996.
23. Corey, E., and Corey, M. J. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects. Int. J. Cancer, 77: 655-673, 1998.
24. Freeman, W. M., Walker, S. J., and Vrana, K. E. Quantitative RT-PCR pitfalls and potential. Biotechniques, 26: 112-125, 1999.
25. Rappolee, D. Optimizing the sensitivity of RT-PCR. Amplifications: a Forum for PCR Users, 4: 5-7, 1990.
26. Moretti, T., Koons, B., and Budowle, B. Enhancement of PCR amplification yield and specificity using AmpliTaq Gold DNA polymerase. Biotechniques, 25: 716-722, 1998.
27. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
28. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J., and Heston, W. D. W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306-6310, 1994.
29. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G., DeWolf, W., and Sklar, J. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634-2639, 1994.
30. Wood, D. P., Banks, E. R., Humphreys, S., and Rangnekar, V. M. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J. Histochem. Cytochem., 42: 505-511, 1994.
31. Wood, D. P., Banks, E. R., Humphreys, S., McRoberts, J. W., and Rangnekar, V. M. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer (Phila.), 74: 2533-2540, 1994.
32. Wood, D. P., Jr., and Banerjee, M. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. J. Clin. Oncol., 15: 3451-3457, 1997.
33. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F., and Rosai, J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195-2000, 1995.
34. Sokoloff, M. H., Tso, C. L., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., de Kernion, J., and Belldegrun, A. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients [see comments]. J. Urol., 156: 1560-1566, 1996.
35. Deguchi, T., Yang, M., Ehara, H., Ito, S., Nishino, Y., Takahashi, Y., Ito, Y., Shimokawa, K., Tanaka, T., Imaeda, T., Doi, T., and Kawada, Y. Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. Br. J. Cancer, 75: 634-638, 1997.
36. Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Layton, T. J., Oswin, M. M., Lange, P. H., and Vessella, R. L. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin. Cancer Res., 3: 249-256, 1997.
37. Erlich, H., Gelfand, D., and Sninsky, J. Recent advances in the polymerase chain reaction. Science (Washington DC), 252: 1643-1651, 1991.
38. Higuchi, R. Rapid, efficient extraction for PCR from cells or blood. Amplifications: a Forum for PCR Users, 2: 1-3, 1989.
39. Chelly, J., Concordet, J. P., Kaplan, J. C., and Kahn, A. Illegitimate transcription: transcription of any gene in any cell type. Proc. Natl. Acad. Sci. USA, 86: 2617-2621, 1989.
40. Schoenfeld, A., Luqmani, Y., Smith, D., O'Reilly, S., Shousha, S., Sinnett, H. D., and Coombes, R. C. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res., 54: 2986-2990, 1994.
41. Pantel, K., Cote, R., and Oystein, F. Detection and clinical importance of micrometastatic disease. J. Natl. Cancer Inst., 91: 1113-1124, 1999.
42. Fields, K. K., Elfenbein, G. J., Trudeau, W. L., Perkins, J. B., Janssen, W. E., and Moscinski, L. C. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J. Clin. Oncol., 14: 1868-1876, 1996.
43. Traystman, M. D., Cochran, G. T., Hake, S. J., Kuszynski, C. A., Mann, S. L., Murphy, B. J., Pirruccello, S. J., Zuvanich, E., and Sharp, J. G. Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests. J. Hematother., 6: 551-561, 1997.
44. Gunn, J., McCall, J. L., Yun, K., and Wright, P. A. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab. Investig., 75: 611-616, 1996.
45. Krismann, M., Todt, B., Schroder, J., Gareis, D., Muller, K. M., Seeber, S., and Schutte, J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol., 13: 2769-2775, 1995.
46. Jung, R., Krüger, W., Hosch, S., Holweg, M., Kröger, N., Gutensohn, K., Wagener, C., Neumaier, M., and Zander, A. R., Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br. J. Cancer, 78: 1194-1198, 1998.